Lupus-related antibody shows promise in enhancing cancer treatment efficacy. ScienceDaily . Retrieved March 26, 2025 from www.sciencedaily.com / releases / 2025 / 03 / 250325141527.htm ...

Dr. James Hansen, a Yale Cancer Center researcher, and his team discovered that using an antibody related to lupus they can breach the tumor and trigger an immune response to fight it. He says ...

Like Rituxan, Gazyva is a monoclonal antibody that targets CD20 ... "Genentech eyes lupus market for Gazyva with positive Phase III data readout " was originally created and published by Clinical ...

Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related antibody that can slip, undetected, into "cold" tumors and flip on an ...

After being all-but written off a year ago, AstraZeneca’s anifrolumab has been reborn with new data that suggest it could help to end a drought in treatments for autoimmune disease systemic ...

Belimumab, a monoclonal antibody that targets B lymphocyte stimulator ... met the primary end point in a Phase III trial for systemic lupus erythematosus (SLE). If approved, belimumab would ...

Long-lived plasma cells, which produce autoantibodies in diseases such as systemic lupus erythematosus (SLE), are an as yet unexplored therapeutic target in such antibody-mediated disorders.

Gazyva/Gazyvaro is the only anti-CD20 monoclonal antibody in a randomised ... for the treatment of lupus nephritis. The filing acceptance is based on positive results from the phase III REGENCY ...

buoyed by a new indication in acute lupus nephritis. Prospects for anifrolumab were looking dim in 2018 after it missed the mark in its first phase 3, but positive data in a second study put the ...

Get Instant Summarized Text (Gist) A lupus-related antibody has been found to enhance immune responses against certain tumors by entering "cold" tumors and activating immune reactions. This ...

New Haven, Conn. — Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related antibody that can slip, undetected, into “cold ...